Veradigm Inc.
US ˙ OTCPK ˙ US01988P1084

Introduction

This page provides a comprehensive analysis of the known insider trading history of Jonathan Judge. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Jonathan Judge has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MDRX / Veradigm Inc. Director 174,593
US:PMCS / PMC - Sierra, Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Jonathan Judge. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MDRX / Veradigm Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MDRX / Veradigm Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2018-12-14 MDRX JUDGE JONATHAN 9,622 10.3763 9,622 10.3763 99,841 63 12.2100 17,645 17.67

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDRX / Veradigm Inc. Insider Trades
Insider Sales MDRX / Veradigm Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MDRX / Veradigm Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDRX / Veradigm Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Jonathan Judge as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-06-20 2024-05-31 4 MDRX Veradigm Inc.
Common Stock
A - Award 42,106 174,593 31.78
2022-06-28 2022-06-27 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 12,756 132,487 10.65
2021-05-27 2021-05-25 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 12,056 119,731 11.20
2020-05-22 2020-05-21 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 30,582 107,675 39.67
2019-05-29 2019-05-24 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 19,628 77,093 34.16
2018-12-17 2018-12-14 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
P - Purchase 9,622 57,465 20.11 10.38 99,841 596,274
2018-05-23 2018-05-21 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 15,949 47,843 50.01
2017-05-24 2017-05-22 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 16,765 31,894 110.81
2016-06-01 2016-05-24 4 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Common Stock
A - Award 15,129 15,129
2016-06-01 3 MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
No securities are beneficially owned
0
2016-01-19 2016-01-15 4 PMCS PMC SIERRA INC
Common Stock
D - Sale to Issuer -101,176 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy
M - Exercise -6,338 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -28,125 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -24,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -252,463 101,176 -71.39 11.94 -3,014,661 1,208,143
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 353,639 2.91 7.44 74,400 2,631,074
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 343,639 7.51 6.08 145,920 2,089,325
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 319,639 8.12 6.26 150,120 1,999,342
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 6,338 295,639 2.19 5.68 36,000 1,679,230
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 289,301 9.05 7.50 180,000 2,169,758
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 265,301 9.95 7.85 188,400 2,082,613
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 241,301 4.32 10.15 101,500 2,449,205
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 28,125 231,301 13.84 6.08 171,000 1,406,310
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 203,176 13.39 7.68 184,320 1,560,392
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 179,176 15.47 7.72 185,280 1,383,239
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 24,000 155,176 18.30 8.06 193,440 1,250,719
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 131,176 8.25 7.31 73,100 958,897
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 121,176 8.99 6.68 66,800 809,456
2015-12-08 2015-12-04 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 111,176 9.88 10.33 103,300 1,148,448
2015-05-28 2015-05-26 4 PMCS PMC SIERRA INC
Common Stock
A - Award 16,015 101,176 18.81
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -10,000 0 -100.00
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -10,000 0 -100.00
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise -10,000 0 -100.00
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
S - Sale -30,000 85,161 -26.05 9.16 -274,809 780,100
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 115,161 9.51 7.75 77,500 892,498
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 105,161 10.51 8.67 86,700 911,746
2015-02-17 2015-02-12 4 PMCS PMC SIERRA INC
Common Stock
M - Exercise 10,000 95,161 11.74 8.21 82,100 781,272
2014-05-29 2014-05-27 4 PMCS PMC SIERRA INC
Common Stock
A - Award 13,104 85,161 18.19
2014-05-29 2014-05-27 4 PMCS PMC SIERRA INC
Common Stock
A - Award 18,621 72,057 34.85
2013-06-05 2013-06-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 28,125 28,125
2013-06-05 2013-06-04 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2013-05-30 2013-05-28 4 PMCS PMC SIERRA INC
Common Stock
A - Award 6,452 53,436 13.73
2013-05-30 2013-05-28 4 PMCS PMC SIERRA INC
Common Stock
A - Award 10,187 46,984 27.68
2012-06-06 2012-06-05 4 PMCS PMC SIERRA INC
Stock Option (Right to Buy)
A - Award 24,000 24,000
2012-05-29 2012-05-25 4 PMCS PMC SIERRA INC
Common Stock
A - Award 9,361 36,797 34.12
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)